Effects of Human C-Reactive Protein on Pathogenesis of Features of the Metabolic Syndrome
- 1 April 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 57 (4) , 731-737
Abstract
Major controversy exists as to whether increased C-reactive protein (CRP) contributes to individual components of the metabolic syndrome or is just a secondary response to inflammatory disease processes. We measured blood pressure and metabolic phenotypes in spontaneously hypertensive rats (SHRs) in which we transgenically expressed human CRP in the liver under control of the apolipoprotein E promoter. In transgenic SHRs, serum levels of human CRP approximated the endogenous levels of CRP normally found in the rat. Systolic and diastolic blood pressures measured by telemetry were 10 to 15 mm Hg greater in transgenic SHRs expressing human CRP than in SHR controls ( P P P P P P P P <0.01), suggesting that oxidative stress may be mediating adverse effects of increased human CRP. These findings are consistent with the hypothesis that increased CRP is more than just a marker of inflammation and can directly promote multiple features of the metabolic syndrome.Keywords
This publication has 31 references indexed in Scilit:
- Human C-Reactive Protein Does Not Promote Atherosclerosis in Transgenic RabbitsCirculation, 2009
- Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivoAtherosclerosis, 2009
- Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart DiseaseJAMA, 2009
- C-reactive protein stimulates superoxide anion release and tissue factor activity in vivoAtherosclerosis, 2009
- Inhibition of Endothelial Nitric Oxide Synthase by C-Reactive Protein: Clinical RelevanceClinical Chemistry, 2009
- Adeno-Associated Virus–Mediated Human C-Reactive Protein Gene Delivery Causes Endothelial Dysfunction and Hypertension in RatsClinical Chemistry, 2009
- The Evolving Role of C-Reactive Protein in AtherothrombosisClinical Chemistry, 2009
- Neointimal formation is reduced after arterial injury in human crp transgenic miceAtherosclerosis, 2008
- Exaggerated Neointima Formation in Human C-Reactive Protein Transgenic Mice Is IgG Fc Receptor Type I (FcγRI)-DependentThe American Journal of Pathology, 2008
- Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemiaProceedings of the National Academy of Sciences, 2007